IASIS PHARMA PARTICIPATION at the 7th PANHELLENIC CONFERENCE OF S.S.D.A.D.

18/10/2024|All articles, Press Room, Scientific conferences|

09/12-15/2024, Portaria Hotel / Pilion During 09/12-15/2024, at Portaria Hotel / Pilion, the Society for the Study of Dermatovenereologic and Allergic Diseases (S.S.D.A.D.) organized the 7th Panhellenic Conference “Dermatological diseases: Past, present and future”. Greek Dermatologists attended the congress and visited IASIS PHARMA exhibition stand to get informed of 3 important IASIS Dermatological products: Isotroin®/ Isotretinoin, (at the new & [...]

PARTICIPATION OF IASIS PHARMA IN THE 2024 Hellenic Osteoporosis Foundation Conference (HELIOS)

17/10/2024|All articles, Press Room, Scientific conferences|

13 – 15/09/2024, MONTANA Hotel Karpenisi IASIS PHARMA participated in the HELLENIC OSTEOPOROSIS FOUNDATION CONFERENCE (HELIOS), held in Karpenisi, at the Montana Hotel, from September 13 to 15, 2024. The Panhellenic conference of the Hellenic Osteoporosis Foundation (ΗELIOS) is the main scientific event of the HELIOS Foundation, involving participations of medical specialties dealing with Osteoporosis and Metabolic Diseases, [...]

IASIS PHARMA PARTICIPATION at the 3rd Innovation@ASygros Congress

28/05/2024|All articles, Press Room, Scientific conferences|

05/23-25/2024. Athens Concert Hall, Hellas IASIS PHARMA participated in the 3rd Innovation@ASygros Congress held on May 23 - 25, 2024 at the Concert Hall in Athens. The conference was organized by the First University Clinic of Venereal and Skin Diseases of the Andreas Sygros Hospital. Greek Dermatologists attended the congress and had the chance to [...]

IASIS PHARMA PARTICIPATION in the 29th PANHELLENIC CONFERENCE on HELICOBACTER PYLORI & OTHER PEPTIC INFECTIONS

23/05/2024|All articles, Exploiting the gifts of Greek nature, Press Room, Scientific conferences|

04/18/24 – 04/21/2024 Hotel Montana, Karpenisi IASIS PHARMA participated with great success for another year in the 29th  Panhellenic Conference on Helicobacter Pylori & Other Peptic Infections, which was held under the auspices of the Medical Association of Evritania and was held at the hotel Montana on 18 – 21/04/2024 in Karpenisi. IASIS PHARMA presented [...]

IASIS PHARMA PARTICIPATION AT THE 19th INTERNATIONAL CONGRESS OF DERMATOLOGY & VENEROLOGY

14/05/2024|All articles, Company news, Scientific conferences|

Thessalonki, 18 - 21/04/2024 Makedonia Palace IASIS PHARMA participated in the 19th International Congress of Dermatology & Venereology held on April 18-21, 2024, at the "Makedonia Palace" hotel in Thessaloniki. The conference was organized by the Hellenic Dermatology & Venereology Society. Greek Dermatologists attended the congress and had the chance to visit IASIS PHARMA exhibition stand and got [...]

PARTICIPATION OF IASIS PHARMA IN THE “22nd PANHELLENIC DIABETES CONGRESS”

02/04/2024|All articles, Press Room, Scientific conferences|

Athens, 27 – 30/03/2024, Divani Caravel Hotel IASIS PHARMA participated at the “22nd PANHELLENIC DIABETES CONGRESS”, held in Athens, at the Divani Caravel Hotel, showing its active interest in Diabetes Mellitus disease, promoting cornerstone pharmaceutical products for type 2 diabetes. Moreover, IASIS PHARMA is about to invest significantly in T2DM in the near future, launching [...]

NEW ZYLAPOUR® – ALLOPURINOL PACKAGING: 100 MG x 100 TABS

28/02/2024|All articles, Press Room, Product launches|

IASIS PHARMA is pleased to announce the launch of the new Zylapour® 100 mg x 100 tabs package, which expands the existing Zylapour® 100 mg x 30 tabs & Zylapour® 300 mg x 30 packages. The active substance of Zylapour® is Allopurinol. Allopurinol is in the class of medications called xanthine oxidase inhibitors and it was approved for medical [...]

PARTICIPATION OF IASIS PHARMA IN THE “SEMINARS OF THE CARDIOLOGY WORKING GROUPS” of the HELLENIC SOCIETY OF CARDIOLOGY

20/02/2024|All articles, Press Room, Scientific conferences|

15 – 17/02/2024 Grand Hyatt Hotel, Athens IASIS PHARMA participated at the “Seminars of the Cardiology Working Groups”, held in Athens, at the Grand Hyatt Athens Hotel, from February 15 to 17, 2024. In IASIS PHARMA exhibition stand, the following products were presented: RosuZet®: New Product Launching. Fixed-dose combination of Rosuvastatin & Ezetimibe, in a single [...]

PRESS RELEASE: CHANGE COLOURATION OF CALCIFORM FAMILY EFFERVECENT TABLETS

06/02/2024|All articles, Company news, Press Room|

We would like to inform you that from 1/15/2024, the tablets coloration of the Calciform® family has changed by virtue of ensuring quality and optimization of the physicochemical characteristics of our products. More specifically the excipient pigment of the effervescent tablets Calciform® – Calcium Carbonate 500mg and Calciform D3® – Calcium Carbonate & Cholecalciferol (1000mg +880 IU), has [...]

IASIS PHARMA PARTICIPATION in the 1st INTERNATIONAL CONGRESS “THESSDERMA”

30/01/2024|All articles, Press Room, Scientific conferences|

26-28/01/2024 Hyatt Regency Hotel, Thessaloniki IASIS PHARMA participated in the 1st International Congress “Thessderma Innovation, Inspiration, Interaction” which held on January 26-28, 2024, at the Hyatt Regency Hotel, in Thessaloniki. The conference was organized by the A' & B' Dermatology Clinics of the Aristotle University of Thessaloniki (A.U.Th.). Dermatologists from all over Greece who attended [...]

Load More Posts